267 related articles for article (PubMed ID: 24516647)
1. Development and validation of a chemostat gut model to study both planktonic and biofilm modes of growth of Clostridium difficile and human microbiota.
Crowther GS; Chilton CH; Todhunter SL; Nicholson S; Freeman J; Baines SD; Wilcox MH
PLoS One; 2014; 9(2):e88396. PubMed ID: 24516647
[TBL] [Abstract][Full Text] [Related]
2. Comparison of planktonic and biofilm-associated communities of Clostridium difficile and indigenous gut microbiota in a triple-stage chemostat gut model.
Crowther GS; Chilton CH; Todhunter SL; Nicholson S; Freeman J; Baines SD; Wilcox MH
J Antimicrob Chemother; 2014 Aug; 69(8):2137-47. PubMed ID: 24788662
[TBL] [Abstract][Full Text] [Related]
3. Biofilms harbour Clostridioides difficile, serving as a reservoir for recurrent infection.
Normington C; Moura IB; Bryant JA; Ewin DJ; Clark EV; Kettle MJ; Harris HC; Spittal W; Davis G; Henn MR; Ford CB; Wilcox MH; Buckley AM
NPJ Biofilms Microbiomes; 2021 Feb; 7(1):16. PubMed ID: 33547298
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of Brazilian red propolis on planktonic and biofilm forms of Clostridioides difficile.
Costa CL; Azevedo CP; Quesada-Gómez C; Brito GAC; Regueira-Neto MDS; Guedes GMM; Rocha MFG; Sidrim JJC; Cordeiro RA; Carvalho CBM; Castelo-Branco DSCM
Anaerobe; 2021 Jun; 69():102322. PubMed ID: 33515722
[TBL] [Abstract][Full Text] [Related]
5. Simulating distal gut mucosal and luminal communities using packed-column biofilm reactors and an in vitro chemostat model.
McDonald JA; Fuentes S; Schroeter K; Heikamp-deJong I; Khursigara CM; de Vos WM; Allen-Vercoe E
J Microbiol Methods; 2015 Jan; 108():36-44. PubMed ID: 25462016
[TBL] [Abstract][Full Text] [Related]
6. An In Vitro Model of the Human Colon: Studies of Intestinal Biofilms and Clostridium difficile Infection.
Crowther GS; Wilcox MH; Chilton CH
Methods Mol Biol; 2016; 1476():223-34. PubMed ID: 27507345
[TBL] [Abstract][Full Text] [Related]
7. Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficile.
Ðapa T; Leuzzi R; Ng YK; Baban ST; Adamo R; Kuehne SA; Scarselli M; Minton NP; Serruto D; Unnikrishnan M
J Bacteriol; 2013 Feb; 195(3):545-55. PubMed ID: 23175653
[TBL] [Abstract][Full Text] [Related]
8. High sporulation and overexpression of virulence factors in biofilms and reduced susceptibility to vancomycin and linezolid in recurrent Clostridium [Clostridioides] difficile infection isolates.
Tijerina-Rodríguez L; Villarreal-Treviño L; Baines SD; Morfín-Otero R; Camacho-Ortíz A; Flores-Treviño S; Maldonado-Garza H; Rodríguez-Noriega E; Garza-González E
PLoS One; 2019; 14(7):e0220671. PubMed ID: 31365590
[TBL] [Abstract][Full Text] [Related]
9. Biofilm regulation in Clostridioides difficile: Novel systems linked to hypervirulence.
Taggart MG; Snelling WJ; Naughton PJ; La Ragione RM; Dooley JSG; Ternan NG
PLoS Pathog; 2021 Sep; 17(9):e1009817. PubMed ID: 34499698
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the effect of the adsorbent DAV131A on the propensity of moxifloxacin to induce simulated Clostridioides (Clostridium) difficile infection (CDI) in an in vitro human gut model.
Chilton CH; Crowther GS; Miossec C; de Gunzburg J; Andremont A; Wilcox MH
J Antimicrob Chemother; 2020 Jun; 75(6):1458-1465. PubMed ID: 32097465
[TBL] [Abstract][Full Text] [Related]
11. Biofilm formation by Clostridium difficile.
Dapa T; Unnikrishnan M
Gut Microbes; 2013; 4(5):397-402. PubMed ID: 23892245
[TBL] [Abstract][Full Text] [Related]
12. Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection.
Theriot CM; Young VB
Gut Microbes; 2014; 5(1):86-95. PubMed ID: 24335555
[TBL] [Abstract][Full Text] [Related]
13. Recurrence of dual-strain Clostridium difficile infection in an in vitro human gut model.
Crowther GS; Chilton CH; Todhunter SL; Nicholson S; Freeman J; Wilcox MH
J Antimicrob Chemother; 2015 Aug; 70(8):2316-21. PubMed ID: 25925596
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of vancomycin extended-dosing regimens for treatment of simulated Clostridium difficile infection within an in vitro human gut model.
Crowther GS; Chilton CH; Longshaw C; Todhunter SL; Ewin D; Vernon J; Karas A; Wilcox MH
J Antimicrob Chemother; 2016 Apr; 71(4):986-91. PubMed ID: 26755495
[TBL] [Abstract][Full Text] [Related]
15. Omadacycline Gut Microbiome Exposure Does Not Induce Clostridium difficile Proliferation or Toxin Production in a Model That Simulates the Proximal, Medial, and Distal Human Colon.
Moura IB; Buckley AM; Ewin D; Shearman S; Clark E; Wilcox MH; Chilton CH
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455242
[TBL] [Abstract][Full Text] [Related]
16. Method comparison for the direct enumeration of bacterial species using a chemostat model of the human colon.
Moura IB; Normington C; Ewin D; Clark E; Wilcox MH; Buckley AM; Chilton CH
BMC Microbiol; 2020 Jan; 20(1):2. PubMed ID: 31898476
[TBL] [Abstract][Full Text] [Related]
17. Planktonic and Sessile Artificial Colonic Microbiota Harbor Distinct Composition and Reestablish Differently upon Frozen and Freeze-Dried Long-Term Storage.
Bircher L; Schwab C; Geirnaert A; Greppi A; Lacroix C
mSystems; 2020 Jan; 5(1):. PubMed ID: 31964766
[TBL] [Abstract][Full Text] [Related]
18. Survival of Planktonic and Sessile Cells of Lactobacillus rhamnosus and Lactobacillus reuteri upon Exposure to Simulated Fasting-State Gastrointestinal Conditions.
Klopper KB; Bester E; Deane SM; Wolfaardt GM; Dicks LMT
Probiotics Antimicrob Proteins; 2019 Jun; 11(2):594-603. PubMed ID: 29785498
[TBL] [Abstract][Full Text] [Related]
19. A modified R-type bacteriocin specifically targeting Clostridium difficile prevents colonization of mice without affecting gut microbiota diversity.
Gebhart D; Lok S; Clare S; Tomas M; Stares M; Scholl D; Donskey CJ; Lawley TD; Govoni GR
mBio; 2015 Mar; 6(2):. PubMed ID: 25805733
[TBL] [Abstract][Full Text] [Related]
20. Fusobacteriumnucleatum Adheres to Clostridioides difficile via the RadD Adhesin to Enhance Biofilm Formation in Intestinal Mucus.
Engevik MA; Danhof HA; Auchtung J; Endres BT; Ruan W; Bassères E; Engevik AC; Wu Q; Nicholson M; Luna RA; Garey KW; Crawford SE; Estes MK; Lux R; Yacyshyn MB; Yacyshyn B; Savidge T; Britton RA; Versalovic J
Gastroenterology; 2021 Mar; 160(4):1301-1314.e8. PubMed ID: 33227279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
